206 related articles for article (PubMed ID: 36230952)
1. ATPase Thorase Deficiency Causes α-Synucleinopathy and Parkinson's Disease-like Behavior.
Gao F; Zhang H; Yang J; Cai M; Yang Q; Wang H; Xu Y; Chen H; Hu Y; He W; Zhang J
Cells; 2022 Sep; 11(19):. PubMed ID: 36230952
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson's disease.
Jakova E; Moutaoufik MT; Lee JS; Babu M; Cayabyab FS
Transl Neurodegener; 2022 Feb; 11(1):9. PubMed ID: 35139916
[TBL] [Abstract][Full Text] [Related]
3. GV-971 attenuates α-Synuclein aggregation and related pathology.
Yu Z; Yang Y; Chan RB; Shi M; Stewart T; Huang Y; Liu Z; Lan G; Sheng L; Tian C; Yang D; Zhang J
CNS Neurosci Ther; 2024 Feb; 30(2):e14393. PubMed ID: 37563872
[TBL] [Abstract][Full Text] [Related]
4. Cx3cr1-deficiency exacerbates alpha-synuclein-A53T induced neuroinflammation and neurodegeneration in a mouse model of Parkinson's disease.
Castro-Sánchez S; García-Yagüe ÁJ; López-Royo T; Casarejos M; Lanciego JL; Lastres-Becker I
Glia; 2018 Aug; 66(8):1752-1762. PubMed ID: 29624735
[TBL] [Abstract][Full Text] [Related]
5. The AAA+ ATPase Thorase regulates AMPA receptor-dependent synaptic plasticity and behavior.
Zhang J; Wang Y; Chi Z; Keuss MJ; Pai YM; Kang HC; Shin JH; Bugayenko A; Wang H; Xiong Y; Pletnikov MV; Mattson MP; Dawson TM; Dawson VL
Cell; 2011 Apr; 145(2):284-99. PubMed ID: 21496646
[TBL] [Abstract][Full Text] [Related]
6. Genetic and pharmacological reduction of CDK14 mitigates synucleinopathy.
Parmasad JA; Ricke KM; Nguyen B; Stykel MG; Buchner-Duby B; Bruce A; Geertsma HM; Lian E; Lengacher NA; Callaghan SM; Joselin A; Tomlinson JJ; Schlossmacher MG; Stanford WL; Ma J; Brundin P; Ryan SD; Rousseaux MWC
Cell Death Dis; 2024 Apr; 15(4):246. PubMed ID: 38575601
[TBL] [Abstract][Full Text] [Related]
7. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice.
Pavia-Collado R; Cóppola-Segovia V; Miquel-Rio L; Alarcón-Aris D; Rodríguez-Aller R; Torres-López M; Paz V; Ruiz-Bronchal E; Campa L; Artigas F; Montefeltro A; Revilla R; Bortolozzi A
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805843
[TBL] [Abstract][Full Text] [Related]
8. AMPA Receptor Surface Expression Is Regulated by S-Nitrosylation of Thorase and Transnitrosylation of NSF.
Umanah GKE; Ghasemi M; Yin X; Chang M; Kim JW; Zhang J; Ma E; Scarffe LA; Lee YI; Chen R; Tangella K; McNamara A; Abalde-Atristain L; Dar MA; Bennett S; Cortes M; Andrabi SA; Doulias PT; Ischiropoulos H; Dawson TM; Dawson VL
Cell Rep; 2020 Nov; 33(5):108329. PubMed ID: 33147468
[TBL] [Abstract][Full Text] [Related]
9. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
[TBL] [Abstract][Full Text] [Related]
10. Association between Decreased SGK1 and Increased Intestinal α-Synuclein in an MPTP Mouse Model of Parkinson's Disease.
Seo MH; Kwon D; Kim SH; Yeo S
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003598
[TBL] [Abstract][Full Text] [Related]
11. A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
Cosden M; Jinn S; Yao L; Gretzula CA; Kandebo M; Toolan D; Hatcher NG; Ma L; Lemaire W; Adam GC; Burlein C; Minnick C; Flick R; Watt ML; Mulhearn J; Fraley M; Drolet RE; Marcus JN; Smith SM
Neurobiol Dis; 2021 Nov; 159():105507. PubMed ID: 34509608
[TBL] [Abstract][Full Text] [Related]
12. Increased Lysosomal Exocytosis Induced by Lysosomal Ca
Tsunemi T; Perez-Rosello T; Ishiguro Y; Yoroisaka A; Jeon S; Hamada K; Rammonhan M; Wong YC; Xie Z; Akamatsu W; Mazzulli JR; Surmeier DJ; Hattori N; Krainc D
J Neurosci; 2019 Jul; 39(29):5760-5772. PubMed ID: 31097622
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-26a/Death-Associated Protein Kinase 1 Signaling Induces Synucleinopathy and Dopaminergic Neuron Degeneration in Parkinson's Disease.
Su Y; Deng MF; Xiong W; Xie AJ; Guo J; Liang ZH; Hu B; Chen JG; Zhu X; Man HY; Lu Y; Liu D; Tang B; Zhu LQ
Biol Psychiatry; 2019 May; 85(9):769-781. PubMed ID: 30718039
[TBL] [Abstract][Full Text] [Related]
14. The AAA + ATPase Thorase is neuroprotective against ischemic injury.
Zhang J; Yang J; Wang H; Sherbini O; Keuss MJ; Umanah GK; Pai EL; Chi Z; Paldanius KM; He W; Wang H; Andrabi SA; Dawson TM; Dawson VL
J Cereb Blood Flow Metab; 2019 Sep; 39(9):1836-1848. PubMed ID: 29658368
[TBL] [Abstract][Full Text] [Related]
15. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside regulation of AMPA receptor trafficking.
Prendergast J; Umanah GK; Yoo SW; Lagerlöf O; Motari MG; Cole RN; Huganir RL; Dawson TM; Dawson VL; Schnaar RL
J Neurosci; 2014 Sep; 34(39):13246-58. PubMed ID: 25253868
[TBL] [Abstract][Full Text] [Related]
17. Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease.
Yang J; Luo S; Zhang J; Yu T; Fu Z; Zheng Y; Xu X; Liu C; Fan M; Zhang Z
Neurobiol Dis; 2021 Jan; 148():105218. PubMed ID: 33296726
[TBL] [Abstract][Full Text] [Related]
18. Genetic deletion of nitric oxide synthase 2 ameliorates Parkinson's disease pathology and neuroinflammation in a transgenic mouse model of synucleinopathy.
Kim J; Han JY; Lee Y; Kim K; Choi YP; Chae S; Hoe HS
Mol Brain; 2023 Jan; 16(1):7. PubMed ID: 36647152
[TBL] [Abstract][Full Text] [Related]
19. Synthetic Peucedanocoumarin IV Prevents α-Synuclein Neurotoxicity in an Animal Model of Parkinson's Disease.
Kim H; Maeng HJ; Kim JH; Yoon JH; Oh Y; Paek SM; Lee Y
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955753
[TBL] [Abstract][Full Text] [Related]
20. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
